ID

31000

Description

A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers; ODM derived from: https://clinicaltrials.gov/show/NCT00743769

Lien

https://clinicaltrials.gov/show/NCT00743769

Mots-clés

  1. 09/07/2018 09/07/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

9 juillet 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Myocardial Infarction NCT00743769

Eligibility Myocardial Infarction NCT00743769

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
in good health with no underlying medical condition that, according to the investigator, would place a subject at risk
Description

Good health | Absence Other medical condition At risk Patient

Type de données

boolean

Alias
UMLS CUI [1]
C3813622
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C3843040
UMLS CUI [2,3]
C1444641
UMLS CUI [2,4]
C0030705
having given written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of any malignancy
Description

Malignant Neoplasms

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
use of any tobacco product within 7 years of study entry
Description

Tobacco use

Type de données

boolean

Alias
UMLS CUI [1]
C0543414
pregnant or lactating women
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of drug abuse
Description

Drug abuse

Type de données

boolean

Alias
UMLS CUI [1]
C0013146
clinically significant abnormal screening ecg
Description

Electrocardiogram abnormal

Type de données

boolean

Alias
UMLS CUI [1]
C0522055
abnormal vital signs
Description

Abnormal vital signs

Type de données

boolean

Alias
UMLS CUI [1]
C0277804
use of systemic steroidal therapy), immunotherapy, cytotoxic, chemotherapy or any investigational drug or device within 30 days of study entry. topical steroids are allowed
Description

Steroid therapy Systemic | Immunotherapy | Cytotoxic therapy | Chemotherapy | Investigational New Drugs | Investigational Medical Device | Topical steroids allowed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0149783
UMLS CUI [1,2]
C0205373
UMLS CUI [2]
C0021083
UMLS CUI [3]
C0677881
UMLS CUI [4]
C0392920
UMLS CUI [5]
C0013230
UMLS CUI [6]
C2346570
UMLS CUI [7,1]
C2064827
UMLS CUI [7,2]
C0683607
women, 40 years of age and above, who have not had a mammography within one year of study entry
Description

Gender | Age | Mammography Absent

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C0024671
UMLS CUI [3,2]
C0332197
men and women, 50 years of age and above, who have not had a sigmoidoscopy within 5 years and colonoscopy within 10 years of study entry
Description

Age | Sigmoidoscopy Absent | Colonoscopy Absent

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0037075
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0009378
UMLS CUI [3,2]
C0332197

Similar models

Eligibility Myocardial Infarction NCT00743769

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Good health | Absence Other medical condition At risk Patient
Item
in good health with no underlying medical condition that, according to the investigator, would place a subject at risk
boolean
C3813622 (UMLS CUI [1])
C0332197 (UMLS CUI [2,1])
C3843040 (UMLS CUI [2,2])
C1444641 (UMLS CUI [2,3])
C0030705 (UMLS CUI [2,4])
Informed Consent
Item
having given written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms
Item
evidence of any malignancy
boolean
C0006826 (UMLS CUI [1])
Tobacco use
Item
use of any tobacco product within 7 years of study entry
boolean
C0543414 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Drug abuse
Item
history of drug abuse
boolean
C0013146 (UMLS CUI [1])
Electrocardiogram abnormal
Item
clinically significant abnormal screening ecg
boolean
C0522055 (UMLS CUI [1])
Abnormal vital signs
Item
abnormal vital signs
boolean
C0277804 (UMLS CUI [1])
Steroid therapy Systemic | Immunotherapy | Cytotoxic therapy | Chemotherapy | Investigational New Drugs | Investigational Medical Device | Topical steroids allowed
Item
use of systemic steroidal therapy), immunotherapy, cytotoxic, chemotherapy or any investigational drug or device within 30 days of study entry. topical steroids are allowed
boolean
C0149783 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2])
C0677881 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C0013230 (UMLS CUI [5])
C2346570 (UMLS CUI [6])
C2064827 (UMLS CUI [7,1])
C0683607 (UMLS CUI [7,2])
Gender | Age | Mammography Absent
Item
women, 40 years of age and above, who have not had a mammography within one year of study entry
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0024671 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Age | Sigmoidoscopy Absent | Colonoscopy Absent
Item
men and women, 50 years of age and above, who have not had a sigmoidoscopy within 5 years and colonoscopy within 10 years of study entry
boolean
C0001779 (UMLS CUI [1])
C0037075 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0009378 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial